Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer
Clinical trial NCT00567554 · COMPLETED
Trial details
- NCT number
- NCT00567554
- Sponsor
- GBG Forschungs GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 2600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.